BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-25 out of 569 found
  Current Search:  u: 569     

HTML
100%
Brave new blogging world
Use blogs, social networking sites and bookmarking sites to place yourself at the centre of a customer community, writes Bryan Collins.

The web is a great platform for businesses to market their services and communicate with customers.

Sunday Business Post:  Jul 5 2008 11:51PM
Matching: u
Find similar documents
HTML
100%
Adolor Provides Update on Entereg(R) (alvimopan) OBD Program
EXTON, Pa.-- (BUSINESS WIRE) -- Adolor Corporation (Nasdaq: ADLR) today issued an update on the Entereg (alvimopan) Program for chronic opioid bowel dysfunction (OBD), under development in collaboration with GlaxoSmithKline (NYSE: GSK).
SmartBrief:  Jul 5 2008 5:37AM
Matching: u
Find similar documents
HTML
100%
Preventing U-100 and U-500 Insulin Mix-Ups: Pass This Information on to Your Doctor & Pharmacist
Recommend this Article: Not at all Somewhat Moderately Highly Very Highly Average Rating: The non-profit Institute for Safe Medication Practices says there has been an increase in reports about mix-ups between prescriptions of insulin U...
Diabetes Health Magazine:  Jul 4 2008 5:01AM
Matching: u
Find similar documents
HTML
100%
'Immune Buildings' Designed to Combat Chemical Warfare and Diseases
UNIVERSITY OF SASKATCHEWAN; JANUSZ KOZINSKI; VENTILATION SYSTEM; TERRORISM; CHEMICAL WARFARE; BIOWARFARE; DISEASE; PUBLIC SAFETY; TERRORIST ATTACKS; TERRORIST ATTACK; Contact Information Available for logged-in reporters only Description...
Newswise:  Jul 4 2008 2:02AM
Matching: u
Find similar documents
HTML
100%
Private Hospitals & Clinics (UK) - Portfolio Analysis Available Now for your Specialised Research
DUBLIN, Ireland-- (BUSINESS WIRE) -- Research and Markets (http://www.researchandmarkets.com/research/d1b0ee/private_hospitals) has announced the addition of the 'Private Hospitals & Clinics (UK) - Portfolio Analysis' report to their...
SmartBrief:  Jul 4 2008 5:37PM
Matching: u
Find similar documents
HTML
100%
Adolor Provides Update on Entereg(R) (alvimopan) OBD Program
- Adolor Corporation (Nasdaq: ADLR) today issued an update on the Entereg(R) (alvimopan) Program for chronic opioid bowel dysfunction (OBD), under development in collaboration with GlaxoSmithKline (NYSE: GSK).

The U.

Food and Drug...

DiGiTAL50:  Jul 4 2008 7:43AM
Matching: u
Find similar documents
HTML
100%
Bentley Pharmaceuticals & Teva Pharmaceutical Industries Ltd. Merger Consideration Established at $14.82 Per S
EXETER, N.H.

Bentley Pharmaceuticals, Inc.

('Bentley') (NYSE: BNT) announced that the aggregate cash purchase price for its acquisition by Teva Pharmaceutical Industries Ltd.

('Teva') has been adjusted in accordance with the merger...

Centre Daily Times:  Jul 4 2008 7:42AM
Matching: u
Find similar documents
HTML
100%
Analysts predict more M&A as capital shrinks
A shortage of new money is likely to drive more and more life sciences companies into , say some of the industry's top analysts.

Money raised from IPOs, venture capital companies and stock sales dropped to a meager $6.5 billion in the...

FierceBiotech:  Jul 4 2008 6:07AM
Matching: u
Find similar documents
HTML
100%
Bentley Pharmaceuticals & Teva Pharmaceutical Industries Ltd. Merger Consideration Established at $14.82 Per S
Bentley Pharmaceuticals, Inc.

(Bentley) (BNT) announced that the aggregate cash purchase price for its acquisition by Teva Pharmaceutical Industries Ltd.

(Teva) has been adjusted in accordance with the merger agreement after completion...

Houston Chronicle:  Jul 3 2008 10:39PM
Matching: u
Find similar documents
HTML
100%
Three New Studies Seek to Advance Lou Gehrig's Disease Care
ALS AMYOTROPHIC LATERAL SCLEROSIS LOU GEHRIG VENTILATOR BIPAP BREATHING Contact Information Available for logged-in reporters only Description Three new studies at the University of Michigan seek to help people with the terminal illness...
Newswise:  Jul 2 2008 11:06PM
Matching: u
Find similar documents
HTML
100%
Treatment of community-onset, childhood convulsive status epilepticus: a prospective, population-based study
Richard FM Chin PhD a c , Brian GR Neville FRCP a b, Catherine Peckham FRCP c, Angie Wade PhD c, Helen Bedford PhD c and Rod C Scott MRCPCH a b d See Reflection and Reaction Summary Background Episodes of childhood convulsive status...
Lancet:  Jul 3 2008 3:07AM
Matching: u
Find similar documents
HTML
100%
Roanmore
The entertainment in the Social Centre for the next week is as follows.

On Sunday, July 6th, Flymac will be playing at the centre, and on July 13th, Crossroads will play at the centre as well.

Please remember also that Thursday night is...

Munster Express:  Jul 3 2008 6:30PM
Matching: u
Find similar documents
HTML
100%
Medical devices center opens at U. Minnesota
Source: Minnesota Daily, U.

Minnesota Tuesday marked the opening of the University of Minnesota's Medical Devices Center , a research facility meant for designing and testing new medical devices.

Director Art Erdman said the center...

U-Wire.com:  Jul 3 2008 10:28AM
Matching: u
Find similar documents
HTML
100%
GM Foods: The U.S. fights mandatory
The U.S.

and several other nations recently attended a Codex meeting in Calgary, Canada to discuss food labeling.

The Codex Alimentarius Commission implements the Joint FAO/WHO Food Standards Program, the purpose of which is to protect...

Checkbiotech:  Jul 3 2008 7:52AM
Matching: u
Find similar documents
HTML
100%
Microza Membranes For Biotech Applications
Pall's polymeric hollow fiber membranes and modules comprise the Microza# range.

Modules range in size from a few square centimeters of surface area through multiple square meters to cover every scale of operation from the laboratory to...

Drug Discovery Online:  Jul 3 2008 3:51AM
Matching: u
Find similar documents
HTML
100%
Bentley Pharmaceuticals & Teva Pharmaceutical Industries Ltd. Merger Consideration Established at $14.82 Per S
EXETER, N.H.--(BUSINESS WIRE)--Bentley Pharmaceuticals, Inc.

(Bentley) (NYSE: BNT - News) announced that the aggregate cash purchase price for its acquisition by Teva Pharmaceutical Industries Ltd.

(Teva) has been adjusted in accordance...

Yahoo! Canada:  Jul 3 2008 9:56PM
Matching: u
Find similar documents
HTML
100%
Bentley Pharmaceuticals & Teva Pharmaceutical Industries Ltd. Merger Consideration Established at $14.82 Per S
EXETER, N.H.--(BUSINESS WIRE)--Bentley Pharmaceuticals, Inc.

( A special meeting of stockholders to vote on the merger has been scheduled for Tuesday, July 22, 2008.

The special stockholders meeting is scheduled to start at 10:00 a.m.

Business Wire:  Jul 3 2008 9:43PM
Matching: u
Find similar documents
HTML
100%
Bentley Pharmaceuticals & Teva Pharmaceutical Industries Ltd. Merger Consideration Established at $14.82 Per S
Bentley Pharmaceuticals, (News) Inc.

( A special meeting of stockholders to vote on the merger has been scheduled for Tuesday, July 22, 2008.

The special stockholders meeting is scheduled to start at 10:00 a.m.

ET at the Hilton Garden...

FinanzNachrichten.de:  Jul 3 2008 9:37PM
Matching: u
Find similar documents
HTML
100%
Teva Provides Update on Generic Seroquel Liti
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd.

(Nasdaq: TEVA) announced today that the U.S.

District Court for the District of New Jersey has issued a decision in its litigation over the Company's Abbreviated New Drug...

Citybizlist:  Jul 3 2008 8:22PM
Matching: u
Find similar documents
HTML
100%
Health Winners & Losers: Abbott Labs
Abbott Labs - hetreet.com M 'undefined') M.cfg 'undefined') //header.jsp adds iframe behind recent quotes popup so it will float over pdf M.cfg.imagesBaseUrl M.cfg.cssBaseUrl thisMarginlag M.cfg.jsBaseUrl M.cfg.staticilePath Global unctions ...
TheStreet.com:  Jul 3 2008 5:08PM
Matching: u
Find similar documents
HTML
100%
Adolor Provides Update on Entereg (alvimopan) OBD Program
- Adolor Corporation (Nasdaq: ADLR) today issued an update on the Entereg(R) (alvimopan) Program for chronic opioid bowel dysfunction (OBD), under development in collaboration with GlaxoSmithKline (NYSE: GSK).

The U.

Food and Drug...

Pharma Live:  Jul 3 2008 3:28PM
Matching: u
Find similar documents
HTML
100%
Adolor Provides Update on Entereg(R) (alvimopan) OBD Program
FDA Lifts Clinical Hold on OBD IND EXTON, Pa.--(BUSINESS WIRE)--Adolor Corporation (Nasdaq: ADLR - News) today issued an update on the Entereg (alvimopan) Program for chronic opioid bowel dysfunction (OBD), under development in collaboration...
Business Wire via Yahoo!:  Jul 3 2008 2:32PM
Matching: u
Find similar documents
HTML
100%
UPDATE 1-Adolor: FDA lifts hold on bowel drug; GSK may exit deal
July 3 (Reuters) - Adolor Corp (ADLR.O: Quote, Profile, Research, Stock Buzz) said U.

health regulators lifted a clinical hold on its drug Entereg, which is being developed to treat bowel dysfunction in patients on opioid therapy,...

Reuters:  Jul 3 2008 2:06PM
Matching: u
Find similar documents
HTML
100%
Adolor Provides Update on Entereg(R) (alvimopan) OBD Program
, 7:30 AM EST News source: Business Wire Adolor Corporation (Nasdaq: ADLR) today issued an update on the Entereg(R) (alvimopan) Program for chronic opioid bowel dysfunction (OBD), under development in collaboration with GlaxoSmithKline (NYSE...
Genetic Engineering News:  Jul 3 2008 12:08PM
Matching: u
Find similar documents
HTML
100%
Adolor Provides Update on Entereg(R) (alvimopan) OBD Program
EXTON, Pa.--(BUSINESS WIRE)-- Adolor Corporation (Nasdaq: ADLR) today issued an update on the Entereg(R) (alvimopan) Program for chronic opioid bowel dysfunction (OBD), under development in collaboration with GlaxoSmithKline (NYSE: GSK).
Street Insider:  Jul 3 2008 12:06PM
Matching: u
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.